305 related articles for article (PubMed ID: 26811623)
1. Management of pancreatic cancer in the elderly.
Higuera O; Ghanem I; Nasimi R; Prieto I; Koren L; Feliu J
World J Gastroenterol; 2016 Jan; 22(2):764-75. PubMed ID: 26811623
[TBL] [Abstract][Full Text] [Related]
2. An onco-geriatric approach to select older patients for optimal treatments of pancreatic adenocarcinoma.
Castel-Kremer E; De Talhouet S; Charlois AL; Graillot E; Chopin-Laly X; Adham M; Comte B; Lombard-Bohas C; Walter T; Boschetti G
J Geriatr Oncol; 2018 Jul; 9(4):373-381. PubMed ID: 29685381
[TBL] [Abstract][Full Text] [Related]
3. [CRITICAL VIEWPOINT ON THE CURRENT APPROACH OF LOCALIZED PANCREATIC DUCTAL ADENOCARCINOMA].
Van Daele D; Martinive P; Loly C; Polus M; Collignon J; Gast P; Louis E; Van Laethem JL
Rev Med Liege; 2015 Nov; 70(11):540-5. PubMed ID: 26738264
[TBL] [Abstract][Full Text] [Related]
4. Impact of early disease progression and surgical complications on adjuvant chemotherapy completion rates and survival in patients undergoing the surgery first approach for resectable pancreatic ductal adenocarcinoma - A population-based cohort study.
Labori KJ; Katz MH; Tzeng CW; Bjørnbeth BA; Cvancarova M; Edwin B; Kure EH; Eide TJ; Dueland S; Buanes T; Gladhaug IP
Acta Oncol; 2016; 55(3):265-77. PubMed ID: 26213211
[TBL] [Abstract][Full Text] [Related]
5. Update on the management of pancreatic cancer: surgery is not enough.
Ansari D; Gustafsson A; Andersson R
World J Gastroenterol; 2015 Mar; 21(11):3157-65. PubMed ID: 25805920
[TBL] [Abstract][Full Text] [Related]
6. Invasive intraductal papillary-mucinous neoplasm of the pancreas: comparison with pancreatic ductal adenocarcinoma.
Murakami Y; Uemura K; Sudo T; Hayashidani Y; Hashimoto Y; Nakashima A; Sueda T
J Surg Oncol; 2009 Jul; 100(1):13-8. PubMed ID: 19384908
[TBL] [Abstract][Full Text] [Related]
7. Multidisciplinary management of locally advanced pancreatic ductal adenocarcinoma.
Alemi F; Alseidi A; Scott Helton W; Rocha FG
Curr Probl Surg; 2015 Sep; 52(9):362-98. PubMed ID: 26363649
[No Abstract] [Full Text] [Related]
8. Follow-up after curative surgery for pancreatic ductal adenocarcinoma: asymptomatic recurrence is associated with improved survival.
Nordby T; Hugenschmidt H; Fagerland MW; Ikdahl T; Buanes T; Labori KJ
Eur J Surg Oncol; 2013 Jun; 39(6):559-66. PubMed ID: 23498362
[TBL] [Abstract][Full Text] [Related]
9. Metastatic Pancreatic Cancer.
Hogendorf P; Durczyński A; Strzelczyk J
J Invest Surg; 2018 Apr; 31(2):151-152. PubMed ID: 28267398
[No Abstract] [Full Text] [Related]
10. Treatment outcomes of pancreatic cancer in the elderly - literature review.
Gajda M; Kenig J
Folia Med Cracov; 2018; 58(3):49-66. PubMed ID: 30521511
[TBL] [Abstract][Full Text] [Related]
11. Irreversible electroporation: a novel therapy for stage III pancreatic cancer.
Weiss MJ; Wolfgang CL
Adv Surg; 2014; 48():253-8. PubMed ID: 25293620
[No Abstract] [Full Text] [Related]
12. Effects of perioperative red blood cell transfusion on disease recurrence and survival after pancreaticoduodenectomy for ductal adenocarcinoma.
Kneuertz PJ; Patel SH; Chu CK; Maithel SK; Sarmiento JM; Delman KA; Staley CA; Kooby DA
Ann Surg Oncol; 2011 May; 18(5):1327-34. PubMed ID: 21369744
[TBL] [Abstract][Full Text] [Related]
13. Guidelines for the management of patients with pancreatic cancer periampullary and ampullary carcinomas.
; ; ; ;
Gut; 2005 Jun; 54 Suppl 5(Suppl 5):v1-16. PubMed ID: 15888770
[No Abstract] [Full Text] [Related]
14. EGFR expression in pancreatic intraepithelial neoplasia and ductal adenocarcinoma.
Park SJ; Gu MJ; Lee DS; Yun SS; Kim HJ; Choi JH
Int J Clin Exp Pathol; 2015; 8(7):8298-304. PubMed ID: 26339400
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological Features of 15 Occult and 178 Clinical Pancreatic Ductal Adenocarcinomas in 8339 Autopsied Elderly Patients.
Matsuda Y; Ishiwata T; Yachida S; Suzuki A; Hamashima Y; Hamayasu H; Yoshimura H; Honma N; Aida J; Takubo K; Arai T
Pancreas; 2016 Feb; 45(2):234-40. PubMed ID: 26474426
[TBL] [Abstract][Full Text] [Related]
16. Pancreaticoduodenectomy for adenocarcinoma of the pancreatic head is justified in elderly patients: A Retrospective Cohort Study.
Renz BW; Khalil PN; Mikhailov M; Graf S; Schiergens TS; Niess H; Boeck S; Heinemann V; Hartwig W; Werner J; Bruns CJ; Kleespies A
Int J Surg; 2016 Apr; 28():118-25. PubMed ID: 26906329
[TBL] [Abstract][Full Text] [Related]
17. Translational advances and novel therapies for pancreatic ductal adenocarcinoma: hope or hype?
Chandana S; Mahadevan D
Expert Rev Mol Med; 2009 Nov; 11():e34. PubMed ID: 19919723
[TBL] [Abstract][Full Text] [Related]
18. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
[TBL] [Abstract][Full Text] [Related]
19. The use of radiofrequency ablation in pancreatic cancer in the midst of the dawn of immuno-oncology.
Reccia I; Kumar J; Habib N; Sodergren M
Med Oncol; 2018 Oct; 35(12):151. PubMed ID: 30284649
[TBL] [Abstract][Full Text] [Related]
20. Elderly patients with advanced pancreatic cancer: the generalizability of the results of clinical trials to daily clinical practice.
Giuliani J; Bonetti A
Recenti Prog Med; 2017 Mar; 108(3):152-154. PubMed ID: 28398410
[No Abstract] [Full Text] [Related]
[Next] [New Search]
